AzTrials
AzTrials

Severe Mental DisordersMEDECO-IPSNCT07206316

Health-economic Evaluation of the IPS (Individual Placement and Support) Model for Helping People With Severe Mental Disorders Access Employment in the Ordinary Labor Market, Compared to Standard Methods of Helping People Return to Work: a Prospective Real-life Study

An observational study of Severe Mental Disorders, run by University Hospital, Tours at 11 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The Individual Placement and Support (IPS) model was developed in the United States in the 1990s to help people with severe mental health issues get back into regular jobs. This model is based on the idea that a quick job search that takes into account what patients want, followed by ongoing and intensive support in… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Severe Mental Disorders
What is being tested?
Individual Placement and Support Model and Standard Method
How many people
234 participants
Where
11 sitesFrance
Study dates
2 Oct 2025to Mar 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients with severe mental disorders treated in adult psychiatric wards and receiving support to return to competitive employment in the open labor market in France

Who may be able to join

  • Aged ≥ 18 years
  • Participant with a chronic psychiatric disorder causing significant functional impairment
  • Unemployed
  • Wishing to return to competitive employment in the open labor market
  • Informed about the study and consenting to participate
  • Able to read french

Who cannot join

  • Individuals not eligible for legal employment due to irregular residency status in France
  • Individuals not affiliated with a social security system
  • Individuals wishing to work in a sheltered/protected setting
  • Individuals currently enrolled in a training program
  • Individuals refusing to participate in the study

Trial locations and contacts

11 sites in 1 country. Contact the study team or a site near you to ask about taking part.

11 sites in 1 country

France11 sites
  • CH Cesame

    Angers, 49000

    Efflam Dr Bregeon, efflam.bregeon@ch-cesame-angers.fr

  • CH George Sand

    Bourges, 18000

    Isabelle Chazalette, isabelle.chazalette@ch-george-sand.fr

  • Centre hospitalier Le Vinatier

    Bron, 69000

    Nadira DALI, nadira.dali@ch-le-vinatier.fr

  • CHI EPSM Oise

    Clermont, 60000

    Marie Cecile Dr Bralet, Marie-Cecile.BRALET@chi-clermont.fr

  • University hospital

    Clermont-Ferrand, 63000

    Isabelle Dr Chereau, ichereau@chu-clermontferrand.fr

  • Centre Hospitalier Marius Lacroix

    La Rochelle, 17000

    Louise LARROQUE, 02 ext. +33, louise.larroque@ght-atlantique17.fr

  • CH Esquirol

    Limoges, 87000

    Emilie Dr Legros-Lafarge, 587509087 ext. +33, emilie.legros-lafarge@ch-esquirol-limoges.fr

  • Hôpital la Colombière

    Montpellier, 34000

    Anaelle DONGAL, a-dongal@chu-montpellier.fr

  • PRISM 45

    Orléans, 45000

    Monique Dr Olland

  • CH Le Rouvray

    Rouen, 76000

    Emeline Dr Duhamel, emeline.duhamel@ch-lerouvray.fr

  • University hospital

    Tours, 37000

    Jérôme GRAUX, 247473756 ext. +33, j.graux@chu-tours.fr

    Helen CLERY, 2 47 47 75 17 ext. +33, H.CLERY@chu-tours.fr

Other trials in France

About this study

The Individual Placement and Support (IPS) model was developed in the United States in the 1990s to help people with severe mental health issues get back into regular jobs. This model is based on the idea that a quick job search that takes into account what patients want, followed by ongoing and intensive support in the community, is especially good for this group. To date, although the effectiveness of the IPS model has been widely demonstrated (for a review, see Metcalfe et al., 2018), only a few studies have evaluated its efficiency in foreign contexts (Knapp et al., 2013; Christensen et al., 2020).

Although the IPS model has been in place in France for around ten years, no studies have yet been conducted to validate its efficiency in the French healthcare system.

The main objective of this prospective, real-life, multicenter study is to evaluate the efficiency of the IPS practice model compared to the conventional method of follow-up by social workers for patients with severe mental illness in terms of cost per additional day worked, from a collective perspective.

Being tested
Individual Placement and Support Model, Standard Method
Keywords
Individual Placement and Support, Health-economic evaluation
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individual Placement and Support ModelOther

    The Individual Placement and Support (IPS) model is an employment support program specifically designed for people with severe mental illness (Bond, Drake, \& Becker, 2012). The core philosophy of IPS is that anyone can obtain competitive employment in the open labor market, provided it is the right job combined with appropriate support.

    IPS support is delivered by a job coach, specifically trained in this model, who devotes their entire working time to assisting patients in their vocational integration.

  • Standard MethodOther

    In psychiatric wards, patients who wish to do so are usually offered support to initiate the process of returning to competitive employment in the open labor market. This assistance is provided by the social workers (such as social workers or educators) within the care unit.

Study groups in NCT07206316
Study groupRoleWhat they receive
IPS (Individual Placement and Support) practice modelpatients benefiting from the IPS (Individual Placement and Support) practice model for assistance in accessing employment
Receives: Other: Individual Placement and Support Model
standard methodpatients benefiting from the standard method for assistance in accessing employment
Receives: Other: Standard Method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficiency of the IPS practice model compared to the conventional method of follow-up by social workers for patients with severe mental illness

    Incremental cost-effectiveness ratio (ICER) expressed as cost per additional day worked at 18 months, from a collective perspective, of the IPS practice model in patients with severe mental disorders.

    Measured: 18 months

Secondary outcomes (8)
  1. Efficiency of the IPS model compared to the conventional method of monitoring by social workers among patients with severe mental illness

    Incremental cost-utility ratio (ICUR) expressed as "cost/QALY gained at 18 months, from a collective perspective, of the IPS model in patients with severe mental disorders.

    Measured: 18 months

  2. Cost-benefit ratio of the IPS practice model compared to the conventional method of follow-up by social workers for patients with severe mental illness,

    Benefit-cost ratio of the IPS model compared to the conventional method of follow-up by social workers at 18 months, from a societal perspective, among patients with severe mental illness

    Measured: 18 months

  3. Budgetary impact on the French national health insurance system (AM) of changes in clinical practices with regard to the two types of support for returning to work.

    Budgetary impact for the Health Insurance system per year and over 5 years of the evolution of practices with regard to the two types of support for return to work

    Measured: 5 years

  4. Compare work productivity and activity disorders between the two groups.

    Comparison of scores on the questionnaire on work productivity and activity impairment (French version of the Work Productivity and Activity Impairment, WPAI)

    Measured: 0, 6, 12 and 18 months

  5. Compare the rate of hospital care use between the two groups.

    Comparison of the number of hospitalizations, number of visits to psychiatric emergency rooms, and number of day hospital visits between the two groups

    Measured: 18 months

  6. Impact of a return to work on patients' level of recovery and overall health.

    Comparison of scores on a clinical scale of recovery and overall health (French version of the Recovery Assessment Scale, RAS) between the two groups

    Measured: 18 months

  7. Impact of a return to work on patients' level of social cognition.

    Comparison of scores on the ACSo clinical social cognition scale between the two groups

    Measured: 18 months

  8. Impact of a return to work on patients' cognitive functioning

    Comparison of scores on the clinical cognitive functioning scale (French version of the Subjective Scale to Investigate Cognition in Schizophrenia, SSTICS) between the two groups

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start2 Oct 2025 (estimated)
  3. Primary completionMar 2030 (estimated)
  4. Study completionMar 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
234 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07206316
Sponsor's protocol ID
DR240280-MEDECO-IPS
Acronym
MEDECO-IPS
Status last verified
Sep 2025
First submitted
25 Sep 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Severe Mental Disorders, run by University Hospital, Tours at 11 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jérôme GRAUX (247473756 ext. +33, j.graux@chu-tours.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficiency of the IPS practice model compared to the conventional method of follow-up by social workers for patients with severe mental illness (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in